Key terms
About LXRX
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest LXRX news
May 03
8:11am ET
Analysts Are Bullish on These Healthcare Stocks: Cigna (CI), Lexicon Pharmaceuticals (LXRX)
May 03
6:52am ET
Optimistic Buy Rating for Lexicon Pharmaceuticals Amid Strong Inpefa Sales Outlook and Efficient Financial Management
May 03
6:33am ET
Needham Keeps Their Hold Rating on Lexicon Pharmaceuticals (LXRX)
May 02
4:36pm ET
Lexicon reports Q1 EPS (20c), consensus (20c)
Apr 30
6:25am ET
Lexicon Pharmaceuticals: A Buy Rating on Strong Market Prospects and Innovative Pipeline
Apr 30
6:18am ET
Lexicon initiated with an Outperform at Leerink
Apr 29
9:17am ET
Lexicon announces CEO Lonnel Coats will retire July 7
Apr 23
6:07am ET
Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)
Apr 23
5:59am ET
Needham Keeps Their Hold Rating on Lexicon Pharmaceuticals (LXRX)
Apr 22
8:50am ET
Lexicon to hold investor day
Apr 22
4:55am ET
Lexicon to hold investor day
Apr 21
2:54pm ET
Lexicon to hold investor day
Mar 25
4:19pm ET
Lexicon files to sell 57.66M shares of common stock for holders
Mar 25
9:23am ET
Lexicon announces presentations of clinical data on sotagliflozin
Mar 14
11:01am ET
Biotech Alert: Searches spiking for these stocks today
Mar 14
7:20am ET
Analysts’ Top Healthcare Picks: REPRO-MED Systems (KRMD), Catalyst Pharma (CPRX)
Mar 13
11:07am ET
Biotech Alert: Searches spiking for these stocks today
Mar 12
8:35am ET
Lexicon announces post hoc analysis of data from inTandem3 Phase 3 trial
Mar 11
12:01pm ET
Analysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)
Mar 11
7:42am ET
Lexicon Pharmaceuticals Launches Strategic Private Placement
Mar 11
7:27am ET
Lexicon announces $250M private equity placement
Mar 11
7:17am ET
Lexicon reports Q4 EPS (20c), consensus (22c)
Mar 11
7:11am ET
Lexicon preparing to resubmit sotagliflozin NDA mid-year
Feb 21
8:45am ET
Largest borrow rate increases among liquid names
Feb 16
8:45am ET
Largest borrow rate increases among liquid names
Feb 14
11:08am ET
Biotech Alert: Searches spiking for these stocks today
Feb 12
8:45am ET
Largest borrow rate increases among liquid names
Feb 09
8:45am ET
Largest borrow rate increases among liquid names
Feb 06
8:45am ET
Largest borrow rate increases among liquid names
Feb 06
4:55am ET
Lexicon management to meet with Piper Sandler
Feb 05
8:45am ET
Largest borrow rate increases among liquid names
No recent press releases are available for LXRX
LXRX Financials
Key terms
Ad Feedback
LXRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
LXRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
